{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T18:22:16Z","timestamp":1771870936518,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,5,18]],"date-time":"2011-05-18T00:00:00Z","timestamp":1305676800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s00280-011-1665-1","type":"journal-article","created":{"date-parts":[[2011,5,17]],"date-time":"2011-05-17T15:16:49Z","timestamp":1305645409000},"page":"1339-1346","source":"Crossref","is-referenced-by-count":38,"title":["Methotrexate toxicity and efficacy during the consolidation phase in paediatric acute lymphoblastic leukaemia and MTHFR polymorphisms as pharmacogenetic determinants"],"prefix":"10.1007","volume":"68","author":[{"given":"Velia","family":"D\u2019Angelo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Ramaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Iannotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Crisci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Indolfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Francese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Carmen","family":"Affinita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Pecoraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Addolorata","family":"Napolitano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matilde","family":"Oreste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiana","family":"Indolfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiorina","family":"Casale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,18]]},"reference":[{"key":"1665_CR1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2125.2006.02591.x","volume":"62","author":"WP Yong","year":"2006","unstructured":"Yong WP, Innocenti F, Ratain MJ (2006) The role of pharmacogenetics in cancer therapeutics. Br J Clin Pharmacol 62:35\u201346","journal-title":"Br J Clin Pharmacol"},{"key":"1665_CR2","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1093\/annonc\/mdf322","volume":"13","author":"P Chiusolo","year":"2002","unstructured":"Chiusolo P, Reddiconto G, Casorelli I et al (2002) Preponderance of methylenetetrahydrofolate reductase C677T homozygosity among leukemia patients intolerant to methotrexate. Annal Oncol 13:1915\u20131918","journal-title":"Annal Oncol"},{"key":"1665_CR3","doi-asserted-by":"crossref","first-page":"13217","DOI":"10.1073\/pnas.95.22.13217","volume":"95","author":"PJ Bagley","year":"1998","unstructured":"Bagley PJ, Selhub J (1998) A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells. Proc Natl Acad Sci USA 95:13217\u201313220","journal-title":"Proc Natl Acad Sci USA"},{"key":"1665_CR4","first-page":"3","volume":"26","author":"H Calvert","year":"1999","unstructured":"Calvert H (1999) An overview of folate metabolism: features relevant to the action and toxicities of antifolate anticancer agents. Semin Oncol 26:3\u201310","journal-title":"Semin Oncol"},{"key":"1665_CR5","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1158\/1055-9965.1436.13.9","volume":"13","author":"S Narayanan","year":"2004","unstructured":"Narayanan S, McConnell J, Little J, Sharp L, Piyathilake C, Powers H, Basten G, Duthie S (2004) Associations between two common variants C677T and A1298C in the methylenetetrahydrofolate reductase gene and measures of folate metabolism and DNA stability (Strand Breaks, Misincorporated uracil, and DNA Methylation Status) in human lymphocytes in vivo. Cancer Epidemiol Biomarkers Prev 13:1436\u20131443","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"1665_CR6","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.leukres.2008.07.026","volume":"33","author":"HN Kim","year":"2009","unstructured":"Kim HN, Kim YK, Lee IK, Yang DH, Lee JJ, Shin MH, Park KS, Choi JS, Park MR, Jo DY, Won JH, Kwak JY, Kim HJ (2009) Association between polymorphisms of folate-metabolizing enzymes and hematological malignancies. Leuk Res 33(1):82\u201387","journal-title":"Leuk Res"},{"key":"1665_CR7","first-page":"659","volume":"19","author":"AK Bottiger","year":"2007","unstructured":"Bottiger AK, Hurtig-Wennlof A, Sjostrom M, Yngve A, Nilsson TK (2007) Association of total plasma homocysteine with methylenetetrahydrofolate reductase genotypes 677C\u00a0>\u00a0T, 1298A\u00a0>\u00a0C, and 1793G\u00a0>\u00a0A and the corresponding haplotypes in Swedish children and adolescents. Int J Mol Med 19:659\u2013665","journal-title":"Int J Mol Med"},{"key":"1665_CR8","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/ijc.10847","volume":"103","author":"G Toffoli","year":"2003","unstructured":"Toffoli G, Russo A, Innocenti F et al (2003) Effect of methylenetetrahydrofolate reductase 677C\u00a0\u2265\u00a0T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients. Int J Cancer 103:294\u2013299","journal-title":"Int J Cancer"},{"key":"1665_CR9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/mgme.1998.2714","volume":"64","author":"I Weisberg","year":"1998","unstructured":"Weisberg I, Tran P, Christensen B, Sibani S, Rozen R (1998) A second genetic polymorphism in methylentetrahydofolaten reductase (MTHFR) associated with decreased enzyme activity. Mole Gene Metabol 64:169\u2013172","journal-title":"Mole Gene Metabol"},{"key":"1665_CR10","first-page":"56","volume":"24","author":"DS Rosenblatt","year":"2001","unstructured":"Rosenblatt DS (2001) Methylenetetrahydrofolate reductase. Clin Invest Med 24:56\u201359","journal-title":"Clin Invest Med"},{"key":"1665_CR11","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/ard.2006.051789","volume":"65","author":"JM Kremer","year":"2006","unstructured":"Kremer JM (2006) Methotrexate pharmacogenomics. Ann Rheum Dis 65:1121\u20131123","journal-title":"Ann Rheum Dis"},{"key":"1665_CR12","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s10038-006-0096-z","volume":"52","author":"H Imanishi","year":"2007","unstructured":"Imanishi H, Okamura N, Yagi M et al (2007) Genetic polymorphisms associated with adverse events and elimination of methotrexate in childhood acute lymphoblastic leukemia and malignant lymphoma. J Hum Genet 52:166\u2013171","journal-title":"J Hum Genet"},{"issue":"8","key":"1665_CR13","first-page":"1113","volume":"91","author":"I Costea","year":"2006","unstructured":"Costea I, Moghrabi A, Laverdiere C, Graziani A, Krajinovic M (2006) Folate cycle gene variants and chemotherapy toxicity in pediatric patients with acute lymphoblastic leukemia. Haematologica 91(8):1113\u20131116","journal-title":"Haematologica"},{"key":"1665_CR14","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1053\/beha.2002.0225","volume":"15","author":"CH Pui","year":"2002","unstructured":"Pui CH, Relling MV, Evans WE (2002) Role of pharmacogenomics and pharmacodynamics in the treatment of acute lymphoblastic leukaemia. Best Pract Res Clin Haematol 15:741\u2013756","journal-title":"Best Pract Res Clin Haematol"},{"key":"1665_CR15","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.leukres.2007.03.028","volume":"31","author":"P Chiusolo","year":"2007","unstructured":"Chiusolo P, Reddiconto G, Farina G et al (2007) MTHFR polymorphisms: influence on outcome and toxicity in acute Lymphoblastic leukemia patients. Leuk Res 31:1669\u20131674","journal-title":"Leuk Res"},{"key":"1665_CR16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/sj.tpj.6500224","volume":"4","author":"M Krajinovic","year":"2004","unstructured":"Krajinovic M, Lemieux-Blanchard E, Chiasson S, Primeau M, Costea I, Moghrabi A (2004) Role of polymorphisms in MTHFR and MTHFD1 genes in the outcome of childhood acute lymphoblastic leukemia. Pharmacogenomics 4:66\u201372","journal-title":"Pharmacogenomics"},{"key":"1665_CR17","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/sj.leu.2402428","volume":"16","author":"JW Taub","year":"2002","unstructured":"Taub JW, Matherly LH, Ravindranath Y et al (2002) Polymorphisms in methylenetetrahydrofolate reductase and methotrexate sensitivity in childhood acute lymphoblastic leukemia. Leukemia 16:764\u2013765","journal-title":"Leukemia"},{"issue":"10","key":"1665_CR18","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.3324\/haematol.2009.008326","volume":"94","author":"A Ongaro","year":"2009","unstructured":"Ongaro A, De Mattei M, Della Porta M, Rigolin G, Ambrosio C, Di Raimondo F, Pellato A, Masieri F, Caruso A, Catozzi L, Gemmati D (2009) Gene polymorfisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate- related toxicity and survival. Haematologica 94(10):1391\u20131398","journal-title":"Haematologica"},{"issue":"6","key":"1665_CR19","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1158\/0008-5472.CAN-04-2606","volume":"65","author":"R Aplenc","year":"2005","unstructured":"Aplenc R, Thompson J, Han P et al (2005) Methylenetetrahydrofolate reductase polymorphisms and therapy response in paediatric acute lymphoblastic leukemia. Cancer Res 65(6):2487\u20132582","journal-title":"Cancer Res"},{"key":"1665_CR20","first-page":"1","volume":"60","author":"E Mattia De","year":"2009","unstructured":"De Mattia E, Toffoli G (2009) G C677T and A1298C MTHFR polymorphisms, a challenge for antifolate and fluoropyrimidine-based therapy. Eu J Cancer 60:1\u201319","journal-title":"Eu J Cancer"},{"key":"1665_CR21","first-page":"101","volume":"6","author":"G Masera","year":"1999","unstructured":"Masera G, Conter V, Rizzari M et al (1999) AIEOP non-B ALL trials. J Ped Haem Onc 6:101","journal-title":"J Ped Haem Onc"},{"key":"1665_CR22","volume-title":"Principles and practice of pediatric oncology","author":"AP Pizzo","year":"2006","unstructured":"Pizzo AP, Poplack DG (2006) Principles and practice of pediatric oncology. Lippincot-Williams and Wilkins, Philadelphia"},{"key":"1665_CR23","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","volume":"33","author":"J Bennet","year":"1976","unstructured":"Bennet J, Catovsky D, Daniel MT, Flandring G, Galton DAG, Gralnick HR, Sultanj C (1976) French-American-British (FAB) cooperative group proposals for the classification of acute leukaemia\u2019s. Br J of Haematol 33:451","journal-title":"Br J of Haematol"},{"issue":"6","key":"1665_CR24","first-page":"1012","volume":"9","author":"JM Bennet","year":"1981","unstructured":"Bennet JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1981) The morphological classification of acute lymphoblastic leukemia: concordance among observers and clinical correlation. Br J of Haematol 9(6):1012","journal-title":"Br J of Haematol"},{"key":"1665_CR25","first-page":"1378","volume":"1325","author":"M Borowitz","year":"1999","unstructured":"Borowitz M, Schuster J, Land V et al (1999) Myeloid\u2014antigen expression in childhood acute lymphoblastic leukemia. N Eng J Med 1325:1378\u20131382","journal-title":"N Eng J Med"},{"key":"1665_CR26","volume-title":"Offset publication no. 48","author":"World Health Organization (WHO) an book For Reporting Results of Cancer Treatment WHO","year":"1979","unstructured":"World Health Organization (WHO) an book For Reporting Results of Cancer Treatment WHO (1979) Offset publication no. 48. World Health Organization, Geneva"},{"key":"1665_CR27","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1038\/sj.leu.2402681","volume":"16","author":"R Aplenc","year":"2002","unstructured":"Aplenc R (2002) Differential bone marrow aspirate DNA yields from commercial extraction kits. Leukemia 16:1865\u20131866","journal-title":"Leukemia"},{"key":"1665_CR28","first-page":"1127","volume":"7","author":"E Boyle","year":"1998","unstructured":"Boyle E, Steinbuchn M, Tekautz T, Gutman J, Robinson J, Perentesis J (1998) Accuracy of DNA amplification from archival haematological slides for use in genetic biomarker studies. Cancer Epidemiol 7:1127\u20131131","journal-title":"Cancer Epidemiol"},{"key":"1665_CR29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0595-111","volume":"10","author":"P Frosst","year":"1995","unstructured":"Frosst P, Blom HJ, Milos R et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111\u2013113","journal-title":"Nat Genet"},{"key":"1665_CR30","first-page":"828","volume":"51","author":"H Refsum","year":"1991","unstructured":"Refsum H, Wesenbrg F, Ueland PM (1991) Plasma homocysteine in children with acute lymphoblastic leukemia: changes during a chemotherapeutic regimen including methotrexate. Cancer Res 51:828\u2013835","journal-title":"Cancer Res"},{"key":"1665_CR31","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/rheumatology\/41.6.658","volume":"41","author":"AE Ede Van","year":"2002","unstructured":"Van Ede AE, Laan RF, Blom HJ, Boers GH, Haagsma CJ, Thomas CM et al (2002) Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis. Rheumatology 41:658\u2013665","journal-title":"Rheumatology"},{"key":"1665_CR32","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1002\/1529-0131(200111)44:11<2525::AID-ART432>3.0.CO;2-B","volume":"44","author":"AE Ede Van","year":"2001","unstructured":"Van Ede AE, Laan RF, Blom HJ, Huizinga TW, Haagsma CJ, Giesendorf BA et al (2001) The C677T mutation in the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients. Arthritis Rheum 44:2525\u20132530","journal-title":"Arthritis Rheum"},{"issue":"5","key":"1665_CR33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/MPH.0b013e318165b25d","volume":"30","author":"N Shimasaki","year":"2008","unstructured":"Shimasaki N, Mori T, Torii C, Sato R, Shimada H, Tanigawara Y, Kosaki K, Takahashi T (2008) Influence of MTHFR and RFC1 polymorphisms on toxicities during maintenance chemotherapy for childhood acute lymphoblastic leukemia or lymphoma. J Pediatr Hematol Oncol 30(5):347\u2013352","journal-title":"J Pediatr Hematol Oncol"},{"issue":"8","key":"1665_CR34","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00277-007-0274-x","volume":"86","author":"S Pakakasama","year":"2007","unstructured":"Pakakasama S, Kanchanakamhaeng K, Kajanachumpol S, Udomsubpayakul U, Sirachainan N, Thithapandha A, Hongeng S (2007) Genetic polymorphisms of folate metabolic enzymes and toxicities of high dose methotrexate in children with acute lymphoblastic leukaemia. Ann Hematol 86(8):609\u2013611 (Epub 2007 Feb 24)","journal-title":"Ann Hematol"},{"issue":"6","key":"1665_CR35","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1080\/10428190902893819","volume":"50","author":"M Kantar","year":"2009","unstructured":"Kantar M, Kosova B, Cetingul N, Gumus S, Toroslu E, Zafer N, Topcuoglu N, Aksoylar S, Cinar M, Tetik A, Eroglu Z (2009) Methylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms and therapy-related toxicity in children treated for acute lymphoblastic leukemia and non-Hodgkin lymphoma. Leuk Lymphoma 50(6):912\u2013917","journal-title":"Leuk Lymphoma"},{"key":"1665_CR36","first-page":"51","volume-title":"Folate-pathway gene variants in cancer: haematological malignancies","author":"A Ongaro","year":"2008","unstructured":"Ongaro A, De Mattei M (2008) Folate-pathway gene variants in cancer: haematological malignancies. Transworld Research Network Editor Donato Gemmati, Kerala, pp 51\u201394"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-011-1665-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-011-1665-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-011-1665-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T19:58:25Z","timestamp":1686081505000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-011-1665-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,18]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["1665"],"URL":"https:\/\/doi.org\/10.1007\/s00280-011-1665-1","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,18]]}}}